Healthcare -
Biotechnology - NASDAQ - US
$ 1.35
-0.746 %
$ 20.3 M
Market Cap
-0.99
P/E
LGVN - LONG-TERM DEBT
Long-term Debt LGVN - Longeveron Inc.
1.65 M
LAST VALUE
-10.14%
2 YEAR CAGR
-14.71%
5 YEAR CAGR
0.00%
10 YEAR CAGR